| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9163721 | Chest | 2005 | 8 Pages |
Abstract
Advanced age alone should not preclude chemotherapy. New single-agent drugs, and non-platinum-based or platinum-based doublets, can all be considered as appropriate treatment for selected fit elderly patients with advanced NSCLC.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Chen MD, PhD, Perng MD, PhD, Shih MD, Tsai MD, Whang-Peng MD,